Management of diabetic foot infections in the light of recent literature and new international guidelines

References

• Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375.
   PubMed Web of Science ®Google Scholar
• Ertuğrul MB, Baktıroğlu S. Diabetic foot and osteomyelitis. J Klimik. 2005;1:8–13.
   Google Scholar
• Lavery LA, Armstrong DG, Murdoch DP, et al. Validation of the infectious diseases society of America’s diabetic foot infection classification system. Clin Infect Dis. 2007;44:562–565.
   PubMed Web of Science ®Google Scholar
• Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018;35(1):78–88.
   PubMed Web of Science ®Google Scholar
• IWGDF. Guideline on the diagnosis and treatment of foot infection in persons with diabetes. [ Assessed 2020 February 3]. https://iwgdfguidelines.org/wp-content/uploads/2019/05/05-IWGDF-infection-guideline-2019.pdf .
   Google Scholar
• Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines. BMJ. 2016;353:2089.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926.
   PubMed Web of Science ®Google Scholar
• Senneville E, Abbas ZG, Aragón-Sánchez J, et al. Diagnosis of infection in the foot in diabetes: a systematic review. Diabetes Metabol Res Rev. 2019. (in press).
   Web of Science ®Google Scholar
• Peters EJG, Senneville E, Abbas ZG, et al. Interventions in the management of infection in the foot in diabetes: a systematic review (update). Diabetes Metabol Res Rev. 2019 (in press).
   Web of Science ®Google Scholar
• Çimşit M, Uzun G, Yıldız S. Hyperbaric oxygen therapy as an anti-infective agent. Expert Rev Anti Infect Ther. 2009;7(8):1015–1026.
   PubMed Web of Science ®Google Scholar
• Kosinski MA, Lipsky BA. Current medical management of diabetic foot infections. Expert Rev Anti Infect Ther. 2010;8(11):1293–1305.
   PubMed Web of Science ®Google Scholar
• Aragón-Sánchez J, Lipsky BA. Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches. Expert Rev Anti Infect Ther. 2018;16(1):35–50.
   PubMed Web of Science ®Google Scholar
• Uçkay I, Gariani K, Pataky Z, et al. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab. 2014;16(4):305–316.
   PubMed Web of Science ®Google Scholar
• Rosskopf AB, Loupatatzis C, Pfirrmann CWA, et al. The Charcot foot: a pictorial review. Insights Imaging. 2019;10(1):77.
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Berendt AR, Cornia PB, et al. 2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):132–173.
   PubMed Web of Science ®Google Scholar
• Rajbhandari SM, Sutton M, Davies C, et al. ‘Sausage toe’: a reliable sign of underlying osteomyelitis. Diabet Med. 2000;17(1):74–77.
   PubMed Web of Science ®Google Scholar
• Ertuğrul BM, Öncül O, Tülek N, et al. A prospective, multi-center study: factors related to the management of diabetic foot infections. Eur J Clin Microbiol Infect Dis. 2012;31(9):2345–2352.
   PubMed Web of Science ®Google Scholar
• Ertuğrul BM, Savk O, Öztürk B, et al. The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values. Med Sci Monit. 2009;15(6):307–312.
   Web of Science ®Google Scholar
• Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA. 1991;266(9):1246–1251.
   PubMed Web of Science ®Google Scholar
• Berendt AR, Peters EJ, Bakker K, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. 2008;24(1):145–161.
   Web of Science ®Google Scholar
• Butalia S, Palda VA, Sargeant RJ, et al. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA. 2008;299(7):806–813.
   PubMed Web of Science ®Google Scholar
• Cavanagh PR, Lipsky BA, Bradbury AW, et al. Treatment for diabetic foot ulcers. Lancet. 2005;366(9498):1725–1735.
   PubMed Web of Science ®Google Scholar
• Ertuğrul MB, Baktıroğlu S, Aksoy M, et al. Diabetic foot and infection. J Klimik. 2004;17(1):3–12.
   Google Scholar
• Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis. 1997;25(6):1318–1326.
   PubMed Web of Science ®Google Scholar
• Lipsky BA. Bone of contention: diagnosing diabetic foot osteomyelitis. Clin Infect Dis. 2008;47(4):528–530.
   PubMed Web of Science ®Google Scholar
• Lipsky BA. Diagnosing and treating diabetic foot infections. Klimik Derg. 2009;22(1):2–13.
   Google Scholar
• Lipsky BA, Peters EJ, Senneville E, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012;28(1):163–178.
   PubMed Web of Science ®Google Scholar
• Jeffcoate WJ, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis. 2004;39(2):115–122.
   PubMed Web of Science ®Google Scholar
• Lam K, van Asten SA, Nguyen T, et al. Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review. Clin Infect Dis. 2016;63(7):944–948.
   PubMed Web of Science ®Google Scholar
• Uzun G, Solmazgül E, Çürüksulu H, et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med. 2007;213(4):305–312.
   PubMed Web of Science ®Google Scholar
• Ertuğrul MB. Diabetic foot infections. Türkiye Klinikleri J Gen Surg-Special Topics. 2010;3(1):46–56.
   Google Scholar
• Van Asten SA, Jupiter DC, Mithani M, et al. Erythrocyte sedimentation rate and C- reactive protein to monitor treatment outcomes in diabetic foot osteomyelitis. Int Wound J. 2017;14(1):142–148.
   PubMed Web of Science ®Google Scholar
• Fleischer AE, Didyk AA, Woods JB, et al. Combined clinical and laboratory testing improves diagnostic accuracy for osteomyelitis in the diabetic foot. J Foot Ankle Surg. 2009;48(1):39–46.
   PubMed Web of Science ®Google Scholar
• Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J Am Podiatr Med Assoc. 2001;91(9):445–450.
   PubMed Web of Science ®Google Scholar
• Malabu UH, Al-Rubeaan KA, Al-Derewish M. Diabetic foot osteomyelitis: usefulness of erythrocyte sedimentation rate in its diagnosis. West Afr J Med. 2007;26(2):113–116.
   PubMedGoogle Scholar
• Hatipoğlu M, Mutluoğlu M, Uzun G, et al. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey. Eur J Clin Microbiol Infect Dis. 2014;33(6):871–878.
   PubMed Web of Science ®Google Scholar
• Ertuğrul BM, Lipsky BA, Savk O. Osteomyelitis or Charcot neuro-osteoarthropathy? Differentiating these disorders in diabetic patients with a foot problem. Diabet Foot Ankle. 2013;4:21855–21863.
   Google Scholar
• Beaman FD, Wessell DE, Cassidy RC, et al. ACR appropriateness criteria® suspected osteomyelitis of the foot in patients with diabetes mellitus. expert panel on musculoskeletal imaging. J Am Coll Radiol. 2019;16(11):440–450.
   Google Scholar
• Glaudemans AW, Uçkay I, Lipsky BA. Challenges in diagnosing infection in the diabetic foot. Diabet Med. 2015;32(6):748–759.
   PubMed Web of Science ®Google Scholar
• Llewellyn A, Jones-Diette J, Kraft J, et al. Imaging tests for the detection of osteomyelitis: a systematic review. Health Technol Assess. 2019;23(61):1–128.
   Web of Science ®Google Scholar
• Ertuğrul MB, Baktiroğlu S, Salman S, et al. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diabet Med. 2006;23(6):649–653.
   PubMed Web of Science ®Google Scholar
• Gariani K, Uçkay I, Lipsky BA. Managing diabetic foot infections: a review of the new guidelines. Acta Chir Belg. 2014;114(1):7–16.
   PubMed Web of Science ®Google Scholar
• Al-Mayahi M, Cian A, Lipsky BA, et al. Administration of antibiotic agents before intraoperative sampling in orthopedic infections alters culture results. J Infect. 2015;71(5):518–525.
   PubMed Web of Science ®Google Scholar
• Jude EB, Selby PL, Mawer EB, et al. Inflammatory and bone turnover markers in Charcot arthropathy and osteomyelitis of the feet in diabetic patients (abstract). Diabetologia. 2002;45(2):341–342.
   Google Scholar
• Çildağ MB, Ertuğrul BM, Köseoğlu OF, et al. Angiographic assessment of atherosclerotic load at the lower extremity in patients with diabetic foot and Charcot neuro-arthropathy. J Chin Med Assoc. 2018;81(6):565–570.
   PubMed Web of Science ®Google Scholar
• Senneville E, Morant H, Descamps D, et al. Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin Infect Dis. 2009;48(7):888–893.
   PubMed Web of Science ®Google Scholar
• Nelson A, Wright-Hughes A, Backhouse MR, et al. CODIFI (Concordance in Diabetic Foot Ulcer Infection): a cross-sectional study of wound swab versus tissue sampling in infected diabetic foot ulcers in England. BMJ Open. 2018;8(1):019437.
   PubMed Web of Science ®Google Scholar
• Tumminello A, Dominguez D, Lebowitz D, et al. Staphylococcus aureus versus streptococci in orthopaedic infections. Infect Dis (Lond). 2017;49(9):716–718.
   PubMed Web of Science ®Google Scholar
• Uçkay I, Pires D, Agostinho A, et al. Enterococci in orthopaedic infections: who is at risk getting infected? J Infect. 2017;75(4):309–314.
   PubMed Web of Science ®Google Scholar
• Abbas M, Uçkay I, Lipsky BA. In diabetic foot infections antibiotics are to treat infection, not to heal wounds. Expert Opin Pharmacother. 2015;16:821–832.
   PubMed Web of Science ®Google Scholar
• Gariani K, Lebowitz D, von Dach E, et al. Remission in diabetic foot infections: duration of antibiotic therapy and other possible associated factors. Diabetes Obes Metab. 2019;21:244–251.
   PubMed Web of Science ®Google Scholar
• Percival SL, Malone M, Mayer D, et al. Role of anaerobes in polymicrobial communities and biofilms complicating diabetic foot ulcers. Int Wound J. 2018;15(5):776–782.
   PubMed Web of Science ®Google Scholar
• Charles PG, Uçkay I, Kressmann B, et al. The role of anaerobes in diabetic foot infections. Anaerobe. 2015;34:8–13.
   PubMed Web of Science ®Google Scholar
• Uçkay I, Gariani K, Dubois-Ferrière V, et al. Diabetic foot infections: recent literature and cornerstones of management. Curr Opin Infect Dis. 2016;29(2):145–152.
   PubMed Web of Science ®Google Scholar
• Selva Olid A, Solà I, Barajas-Nava LA, et al. Systemic antibiotics for treating diabetic foot infections. Cochrane Database Syst Rev. 2015;9:CD009061.
   Google Scholar
• Lebowitz D, Gariani K, Kressmann B, et al. Are antibiotic-resistant pathogens more common in subsequent episodes of diabetic foot infection? Int J Infect Dis. 2017;59:61–64.
   PubMed Web of Science ®Google Scholar
• Uçkay I, Berli M, Sendi P, et al. Principles and practice of antibiotic stewardship in the management of diabetic foot infections. Curr Opin Infect Dis. 2019;32(2):95–101.
   PubMed Web of Science ®Google Scholar
• CDC. Core elements of hospital antibiotic stewardship programs. Atlanta, GA: US Department of Health and Human Services, CDC; 2019 [Assessed 2019 Nov 27]. https://www.cdc.gov/antibiotic-use/healthcare/pdfs/hospital-core-elements-H.pdf
   Google Scholar
• Zenelaj B, Bouvet C, Lipsky BA, et al. Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens? Int J Low Extrem Wounds. 2014;13(4):263–272.
   PubMed Web of Science ®Google Scholar
• Post V, Wahl P, Uçkay I, et al. Phenotypic and genotypic characterisation of Staphylococcus aureus causing musculoskeletal infections. Int J Med Microbiol. 2014;304(5):565–576.
   PubMed Web of Science ®Google Scholar
• Goldstein EJ, Citron DM, Warren YA, et al. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections. Antimicrob Agents Chemother. 2006;50(8):2875–2879.
   PubMed Web of Science ®Google Scholar
• Esposito S, Noviello S, Leone S. Dalbavancin for the treatment of acute bacterial skin and skin structure infections. Infez Med. 2015;23(4):313–317.
   PubMedGoogle Scholar
• Esposito S, De Simone G. Update on the main MDR pathogens: prevalence and treatment options. Infez Med. 2017;25(4):301–310.
   PubMedGoogle Scholar
• Esposito S, Leone S, Noviello S, et al. Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey. Diabet Med. 2008;25(8):979–984.
   PubMed Web of Science ®Google Scholar
• Malik A, Mohammad Z, Ahmad J. The diabetic foot infections: biofilms and antimicrobial resistance. Diabetes Metab Syndr. 2013;7(2):101–107.
   PubMedGoogle Scholar
• Vatan A, Saltoğlu N, Yemisen M, et al. Association between biofilm and multi/extensive drug resistance in diabetic foot infection. Int J Clin Pract. 2018;72(3):e13060.
   PubMed Web of Science ®Google Scholar
• Johani K, Fritz BG, Bjarnsholt T, et al. Understanding the microbiome of diabetic foot osteomyelitis: insights from molecular and microscopic approaches. Clin Microbiol Infect. 2019;25(3):332–339.
   PubMed Web of Science ®Google Scholar
• Wilson BM, Bessesen MT, Doros G, et al. Adjunctive rifampin therapy for diabetic foot osteomyelitis in the veterans health administration. JAMA Network Open. 2019;2(11):1916003.
   Web of Science ®Google Scholar
• Senneville E, Yazdanpanah Y, Cazaubiel M, et al. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother. 2001;48(6):927–930.
   PubMed Web of Science ®Google Scholar
• Bessesen MT, Doros G, Henrie AM, et al. A multicenter randomized placebo controlled trial of rifampin to reduce pedal amputations for osteomyelitis in veterans with diabetes (VA INTREPID). BMC Infect Dis. 2020;20(1):23.
   PubMed Web of Science ®Google Scholar
• Lipsky BA. Treating diabetic foot osteomyelitis primarily with surgery or antibiotics: have we answered the question? Diabetes Care. 2014;37(3):593–595.
   PubMed Web of Science ®Google Scholar
• Lazaro-Martinez JL, Aragon-Sanchez J, Garcia-Morales E. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes Care. 2014;37(3):789–795.
   PubMed Web of Science ®Google Scholar
• Tone A, Nguyen S, Devemy F, et al. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: A multicenter open label controlled randomized study. Diabetes Care. 2015;38:302–307.
   PubMed Web of Science ®Google Scholar
• Waibel F, Berli M, Catanzaro S, et al. Optimization of the antibiotic management of diabetic foot infections: protocol for two randomized-controlled trials. Trials. 2020;21(1):54.
   PubMed Web of Science ®Google Scholar
• Li HK, Rombach I, Zambellas R, et al. Oral versus intravenous antibiotics for bone and joint infection. New Engl J Med. 2019;380(5):425–436.
   PubMed Web of Science ®Google Scholar
• Shiraev TP, Lipsky BA, Kwok TMY, et al. Utility of culturing marginal bone in patients undergoing lower limb amputation for infection. J Foot Ankle Surg. 2019;58(5):847–851.
   PubMed Web of Science ®Google Scholar
• Rossel A, Lebowitz D, Gariani K, et al. Stopping antibiotics after surgical amputation in diabetic foot and ankle infections-A daily practice cohort. Endocrinol Diabetes Metab. 2019;2(2):00059.
   Google Scholar
• Saltoğlu N, Yemisen M, Ö E, et al. Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey. Clin Microbiol Infect. 2015;21:659–664.
   PubMed Web of Science ®Google Scholar
• Kowalski TJ, Matsuda M, Sorenson MD, et al. The effect of residual osteomyelitis at the resection margin in patients with surgically treated diabetic foot infection. J Foot Ankle Surg. 2011;50:171–175.
   PubMed Web of Science ®Google Scholar
• Milne TE, Schoen DE, Bower VM, et al. Benchmarking healing times for diabetic foot ulcerations and investigating the influence of peripheral arterial disease and infection. J Foot Ankle Res. 2011;4:31.
   Google Scholar
• Pence LM, Mock CM, Kays MB, et al. Correlation of adherence to the 2012 infectious diseases society of America practice guidelines with patient outcomes in the treatment of diabetic foot infections in an outpatient parenteral antimicrobial programme. Diabet Med. 2014;31:1114–1120.
   PubMed Web of Science ®Google Scholar
• Catho G, De Kraker M, Waldispühl Suter B, et al. Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the computerized antibiotic stewardship study (COMPASS). BMJ Open. 2018;8:022666.
   Web of Science ®Google Scholar
• Darbellay P, Uçkay I, Dominguez D, et al. Diabetic foot infection: a multidisciplinary approach. Rev Med Suisse. 2011;7(292):894–897.
   PubMedGoogle Scholar
• Sotto A, Richard JL, Combescure C, et al. Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers. Diabetologia. 2010;53:2249–2255.
   PubMed Web of Science ®Google Scholar
• Waibel FWA, Uçkay I, Sairanen K, et al. Diabetic calcaneal osteomyelitis. Infez Med. 2019;27(3):225–238.
   PubMedGoogle Scholar
• Waibel FWA, Klammer A, Götschi T, et al. Outcome after surgical treatment of calcaneal osteomyelitis. Foot Ankle Int. 2019;40(5):562–567.
   PubMed Web of Science ®Google Scholar
• Mueller MJ, Sinacore DR, Hastings MK, et al. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am. 2003;85:1436–1445.
   PubMed Web of Science ®Google Scholar
• Uçkay I, Jornayvaz FR, Lebowitz D, et al. An overview on diabetic foot infections, including issues related to associated pain, hyperglycemia and limb ischemia. Curr Pharm Des. 2018;24:1243–1254.
   PubMed Web of Science ®Google Scholar
• Kim JY, Hwang S, Lee Y. Selective plantar fascia release for nonhealing diabetic plantar ulcerations. J Bone Joint Surg Am. 2012;94:1297–1302.
   PubMed Web of Science ®Google Scholar
• Dumville JC, Lipsky BA, Hoey C, et al. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2017;6:CD011038.
   PubMed Web of Science ®Google Scholar
• Uçkay I, Kressmann B, Di Tommaso S, et al. A randomized controlled trial of the safety and efficacy of a topical gentamicin-collagen sponge in diabetic patients with a mild foot ulcer infection. SAGE Open Med. 2018;6:2050312118773950.
   Web of Science ®Google Scholar
• Uçkay I, Kressmann B, Malacarne S, et al. A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin-collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection. BMC Infect Dis. 2018;18(1):361.
   PubMed Web of Science ®Google Scholar
• Fish R, Kutter E, Wheat G, et al. Compassionate use of bacteriophage therapy for foot ulcer treatment as an effective step for moving toward clinical trials. Methods Mol Biol. 2018;1693:159–170.
   PubMedGoogle Scholar
• Horton R. Offline: The gravy train of systematic reviews. Lancet. 2019;394(10211):1790.
   PubMed Web of Science ®Google Scholar
• Jeffcoate WJ, Bus SA, Game FL, et al. Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality. Lancet Diabetes Endocrinol. 2016;4(9):781–788.
   PubMed Web of Science ®Google Scholar
• Kalan LR, Meisel JS, Loesche MA, et al. Strain- and species-level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy. Cell Host Microbe. 2019;25(5):641–655.
   PubMed Web of Science ®Google Scholar
• Jneid J, Cassir N, Schuldiner S, et al. Exploring the microbiota of diabetic foot infections with culturomics. Front Cell Infect Microbiol. 2018;8:282.
   PubMed Web of Science ®Google Scholar
• Peter-Riesch B. The diabetic foot: the never-ending challenge. Endocr Dev. 2016;31:108–134.
   PubMedGoogle Scholar